Literature DB >> 9205980

Chelation therapy for cardiovascular disease. Review and commentary.

M R Lewin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9205980      PMCID： PMC325409     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  32 in total

1.  The treatment of coronary artery disease with disodium EDTA. A reappraisal.

Authors:  J R KITCHELL; F PALMON; N AYTAN; L E MELTZER
Journal:  Am J Cardiol       Date:  1963-04       Impact factor: 2.778

2.  Treatment of digitalis toxicity by chelation of serum calcium.

Authors:  R S GUBNER; H KALLMAN
Journal:  Am J Med Sci       Date:  1957-08       Impact factor: 2.378

3.  Enhancement of lead excretion in humans by disodium calcium ethylene-diamine tetraacetate.

Authors:  M RUBIN; S GIGNAC; S P BESSMAN; E L BELKNAP
Journal:  Science       Date:  1953-06-12       Impact factor: 47.728

4.  Metabolism and removal of Ca45 in man.

Authors:  J BELLIN; D LASZLO
Journal:  Science       Date:  1953-03-27       Impact factor: 47.728

5.  Referral by default. The medical community and unorthodox therapy.

Authors:  T V Holohan
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

Review 6.  So much writing, so little science: a review of 37 years of literature on edetate sodium chelation therapy.

Authors:  M T Grier; D G Meyers
Journal:  Ann Pharmacother       Date:  1993-12       Impact factor: 3.154

7.  Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects.

Authors:  P Allain; Y Mauras; A Premel-Cabic; S Islam; J P Herve; J Cledes
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

8.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

9.  Properties of neuroprotective cell-permeant Ca2+ chelators: effects on [Ca2+]i and glutamate neurotoxicity in vitro.

Authors:  M Tymianski; M P Charlton; P L Carlen; C H Tator
Journal:  J Neurophysiol       Date:  1994-10       Impact factor: 2.714

10.  Effects of stress management training and dietary changes in treating ischemic heart disease.

Authors:  D Ornish; L W Scherwitz; R S Doody; D Kesten; S M McLanahan; S E Brown; E DePuey; R Sonnemaker; C Haynes; J Lester; G K McAllister; R J Hall; J A Burdine; A M Gotto
Journal:  JAMA       Date:  1983-01-07       Impact factor: 56.272
View more
  6 in total

Review 1.  Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.

Authors:  Ehimen C Aneni; Esteban Escolar; Gervasio A Lamas
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

2.  Opinions on chelation therapy in patients undergoing coronary angiography: cross-sectional survey.

Authors:  Hude Quan; P Diane Galbraith; Colleen M Norris; Danielle A Southern; Kathryn King; Marja J Verhoef; Marril L Knudtson; William A Ghali
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

Review 3.  Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.

Authors:  Gervasio A Lamas; Omar M Issa
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

Review 4.  Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?

Authors:  Gervasio A Lamas; Ian Ergui
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-05

Review 5.  Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.

Authors:  Rossana Calderon Moreno; Ana Navas-Acien; Esteban Escolar; David M Nathan; Jonathan Newman; John F Schmedtje; Denisse Diaz; Gervasio A Lamas; Vivian Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 6.134

Review 6.  EDTA chelation therapy for cardiovascular disease: a systematic review.

Authors:  Dugald M R Seely; Ping Wu; Edward J Mills
Journal:  BMC Cardiovasc Disord       Date:  2005-11-01       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.